2 recruiting, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Stomach Cancer Recurrent: new trials by email Literature Review of Stomach Cancer Recurrent trials Research Report on Stomach Cancer Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TR115 in ARID1A-Mutated Advanced Solid Tumors TR115 - Ovarian Clear Cell Carcinoma, Endometrial Cancer | Phase 2 | Not yet recruiting | Tarapeutics Science Inc. | 50 | 2026-09-20 | 2026-08-28 |
| TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Stomach Cancer, Stomach Cancer Recurrent | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 75 | 2024-09-10 | 2024-11-12 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes PICO G2 4k - Cancer Pain, Visceral Pain | Not applicable | Recruiting | Cedars-Sinai Medical Center | 360 | 2021-10-05 | 2026-11-12 |
Esophageal Neoplasms (2) · Stomach Neoplasms (2) · Adenocarcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Biliary Tract Neoplasms (1) · Cancer Pain (1) · Carcinoid Tumor (1) · Colonic Neoplasms (1) · Endometrial Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Neoplasms (1) · Liver Neoplasms (1) · Neoplasm Metastasis (1)
Neoplasms (3) · Neoplasms by Site (3) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Esophageal Diseases (2) · Gastrointestinal Diseases (2) · Head and Neck Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Stomach Diseases (2) · Adenocarcinoma (1) · Anus Diseases (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1)
Cyclophosphamide (1) · Interleukin-2 (1) · fludarabine (1) · pembrolizumab (1)
Cedars-Sinai Medical Center (1) · Essen Biotech (1) · Tarapeutics Science Inc. (1)
China (2) · United States (1)
Brennan Spiegel, MD, MSHS (1) · Scott Irwin, MD, PhD (1)
R01CA252211 (1)